Rainbow Coral Corp. (RBCC) Takes Initial Steps to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Today before the opening bell, Rainbow Coral announced that it has opened talks this week to potentially partner with an emerging innovator in the transdermal delivery sector. This move is part of the company’s drive to carve out a share of the $142 billion U.S. drug delivery market. Transdermal patches are an increasingly popular drug delivery system that is being developed for everything from contraception to Parkinson's disease. Transdermal drug delivery prevents many of the problems associated with oral and intravenous routes as well as offers major advantages such as improved bioavailability, more uniform plasma levels, longer duration of action,…